Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PegIntron + Rebetol versus PegIntron + placebo for long-term treatment of hepatic fibrosis in chronic hepatitis C non-responders
2005-002937-11Phase 3Completed
- Sponsor
- ANRS
- Start
- Jun 2007
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, DNA Intercalators/Alkylators → Nucleic Acid-Directed Small Molecules → Small Molecules, Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in hepatitis C virus infection and hepatic fibrosis comparing PegIntron + Rebetol with PegIntron + placebo (2 arms). Started Jun 2007; status: completed.
02
Drugs
peginterferon alfa-2bribavirin
03
Conditions
hepatitis C virus infectionhepatic fibrosis
Beyond the preview
Go deeper on 2005-002937-11.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2005-002937-11.